Anti-Cancer Compounds: The Good And The Bad Side

Compounds known as “HDAC inhibitors” exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear.

More: continued here

Filed under: Clinical Trials on April 11th, 2008